Tradestie Institutional Equity Comparison Engine

CELU vs ENSC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while CELU counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, CELU trades at N/M Forward P/E with -254.0% operating margin (-5.3% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
CELU N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner CELU
Op Margin -254.0% vs -281.3% ยท YoY -5.3% vs -15.1%
Momentum & Technical Winner ENSC
1Y -72.6% vs -80.3% ยท 52W Pos 2% vs 8%
Options & Structure Winner CELU
BREAKDOWN (50th %ile IV) vs UNCLASSIFIED (N/A IV)
CELU NASDAQ
Celularity Inc. Class A Common Stock
Pharmaceutical Preparations
$0.46
-1.05% 1D
Market Cap $15.2M
1M Return -55.9%
1Y Return -72.6%
Forward P/E N/M
Unified AI Score
42.9 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 67.0 Mom 55.0
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CELU -72.6% ENSC -80.33% Spread: +7.73 pp (CELU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CELU Revenue ENSC Revenue CELU Op. Margin ENSC Op. Margin Margin Edge
FY2020 $10M $0M -1064.0% -41.0% ENSC
FY2021 $20M $0M -511.2% -562.7% CELU
FY2022 $20M $0M -142.4% -959.9% CELU
FY2023 $20M $0M -844.4% -480.5% ENSC
FY2024 $50M $10M -70.7% -129.2% CELU
FY2025 $30M $10M -230.9% -202.1% ENSC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CELU (3) vs ENSC (6)
Institutional Metric CELU ENSC Criterion Row Winner
Market Capitalization Scale $15.2M $7.0M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 0.8x Lower Multiple ENSC
Forward P/E Ratio Valuation N/M 0.8x Lower Multiple ENSC
Revenue Growth (YoY) Growth -5.3% -15.1% Higher Growth CELU
Operating Margin (TTM) Profitability -254.0% -281.3% Higher Margin CELU
Net Profit Margin Profitability -245.7% -280.5% Higher Margin CELU
Return on Equity (ROE) Capital Efficiency -6367.2% -1295.1% Higher ROE ENSC
52-Week Range Position Momentum 2% ($0โ€“$3) 8% ($0โ€“$2) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 2.01ฮฒ ยท 135% Vol 0.98ฮฒ ยท 79% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 42.9 / 100 (HOLD) 53.4 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CELU vs ENSC Buy Guide
CELU BREAKDOWN
60d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CELU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CELU nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.